login
register
Home
Getting Started
ChartMill Overview
Growth Traders
Technical Swing Traders
Long Term Investors
Tools
Stock Screener
Stock Charts
Full Screen Stock Charts
Market Monitor
Sectors
Earnings
Analyzer
Insider Trading
Up- and Downgrades
Stock Market
Top Gainers and Losers
New 52 Week High and Low
Gap Up and Gap Down
Most Active
Premarket Movers
After-Hours Movers
Earnings Calendar
USA Market Overview
Canada Market Overview
Europe Market Overview
Trading Ideas
News
Blog
Documentation
Documentation Center
Videos
Indicators
Properties
Screener Market data
Popular Articles
Bull Flags
Relative Strength
Pocket Pivots
Support and Resistance
RSI Indicator
MACD Indicator
Piotroski F-score
Squeeze Plays
Weinstein
Technical Breakout Setups
Trading Tips
Premarket Movers
Gap Up Stocks
Best Dividend Stocks
Bullish Engulfing Pattern
Ascending Triangle Pattern
Swing Trading
All articles ...
Subscriptions
Swing Trading Course
Account
Disclaimer
Affiliate
Contact
Privacy
UNITED THERAPEUTICS CORP (UTHR) Stock News
USA
-
Nasdaq
- NASDAQ:UTHR -
US91307C1027
-
Common Stock
474.82
USD
+0.1 (+0.02%)
Last: 11/21/2025, 8:04:10 PM
474.82
USD
0 (0%)
After Hours:
11/21/2025, 8:04:10 PM
Overview
Stock Chart
Technical Analysis
Fundamental Analysis
Analyst Ratings
Earnings Estimates
Financials
Ownership
News
UTHR Latest News, Press Relases and Analysis
All
Press Releases
10 days ago - By: Chartmill
United Therapeutics Corp (NASDAQ:UTHR) Presents a Compelling Value Investment Case
a day ago - By: Zacks Investment Research
Are You a Value Investor? This 1 Stock Could Be the Perfect Pick
2 days ago - By: Zacks Investment Research
Here's Why United Therapeutics (UTHR) is a Strong Growth Stock
3 days ago - By: Benzinga
Here's How Much $100 Invested In United Therapeutics 15 Years Ago Would Be Worth Today
3 days ago - By: Zacks Investment Research
- Mentions:
JNJ
MRK
Merck Stock Rise as New PAH Drug Winrevair Meets Goal in Another Study
10 days ago - By: Zacks Investment Research
Why United Therapeutics (UTHR) is a Top Momentum Stock for the Long-Term
15 days ago - By: Benzinga
Is United Therapeutics Corp Gaining or Losing Market Support?
16 days ago - By: The Motley Fool
- Mentions:
VBR
VOO
VUG
VTV
...
My Top Vanguard Index ETF Pick for 2026
17 days ago - By: Zacks Investment Research
Here's Why United Therapeutics (UTHR) is a Strong Value Stock
18 days ago - By: Zacks Investment Research
Why United Therapeutics (UTHR) is a Top Growth Stock for the Long-Term
18 days ago - By: United Therapeutics Corporation
United Therapeutics Corporation to Present at Upcoming Investor Conferences
19 days ago - By: United Therapeutics Corporation
United Therapeutics Corporation Announces First Transplant in EXPAND Clinical Trial of UKidney in Patients With End-Stage Renal Disease
23 days ago - By: Zacks Investment Research
MKKGY vs. UTHR: Which Stock Is the Better Value Option?
23 days ago - By: The Motley Fool
United Therapeutics (UTHR) Earnings Transcript
23 days ago - By: Investor's Business Daily
- Mentions:
INSM
ARGX
LQDA
Insmed Catapults While IBD 50's Argenx Creeps Higher On Bullish Reports
24 days ago - By: Zacks Investment Research
Compared to Estimates, United Therapeutics (UTHR) Q3 Earnings: A Look at Key Metrics
24 days ago - By: Investor's Business Daily
- Mentions:
NVS
AAPL
United Therapeutics Dips As Bread-And-Butter Drug Comes Up Short
24 days ago - By: United Therapeutics Corporation
United Therapeutics Corporation Reports Record Third Quarter 2025 Financial Results
a month ago - By: Zacks Investment Research
- Mentions:
AMRX
Analysts Estimate Amneal Pharmaceuticals (AMRX) to Report a Decline in Earnings: What to Look Out for
a month ago - By: United Therapeutics Corporation
United Therapeutics Corporation to Report Third Quarter 2025 Financial Results Before Market Open on Wednesday, October 29, 2025
Please enable JavaScript to continue using this application.